BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30731437)

  • 1. A stochastic frontier analysis for enhanced treatment quality of high-dose-rate brachytherapy plans.
    Edimo P; Kroshko A; Beaulieu L; Archambault L
    Phys Med Biol; 2019 Mar; 64(6):065012. PubMed ID: 30731437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel urethral sparing technique for high-dose-rate prostate brachytherapy after transurethral resection of the prostate.
    Kunogi H; Cunha JAM; Chang AJ; Gadzinski AJ; Shinohara K; Hsu IC
    Brachytherapy; 2017; 16(6):1113-1118. PubMed ID: 28869143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
    Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
    Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.
    White EC; Kamrava MR; Demarco J; Park SJ; Wang PC; Kayode O; Steinberg ML; Demanes DJ
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):543-8. PubMed ID: 22652111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment.
    Kamrava M; Chung MP; Kayode O; Wang J; Marks L; Kupelian P; Steinberg M; Park SJ; Demanes DJ
    Brachytherapy; 2013; 12(5):434-41. PubMed ID: 23406987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
    Fukuda S; Seo Y; Shiomi H; Yamada Y; Ogata T; Morimoto M; Konishi K; Yoshioka Y; Ogawa K
    J Radiat Res; 2014 Nov; 55(6):1114-21. PubMed ID: 24957754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
    Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
    Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
    Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
    Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis.
    Banerjee R; Park SJ; Anderson E; Demanes DJ; Wang J; Kamrava M
    Brachytherapy; 2015; 14(3):366-72. PubMed ID: 25680768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
    Mason J; Al-Qaisieh B; Bownes P; Thwaites D; Henry A
    Brachytherapy; 2014; 13(6):611-7. PubMed ID: 25085456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
    Sharma M; Fields EC; Todor DA
    Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical benefits achievable by using different optimization algorithms during real-time prostate brachytherapy.
    Adamczyk M; Zwierzchowski G; Malicki J; Skowronek J
    Phys Med; 2013 Jan; 29(1):111-6. PubMed ID: 22221470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plan quality improvement by DVH sharing and planner's experience: Results of a SBRT multicentric planning study on prostate.
    Villaggi E; Hernandez V; Fusella M; Moretti E; Russo S; Vaccara EML; Nardiello B; Esposito M; Saez J; Cilla S; Marino C; Stasi M; Mancosu P
    Phys Med; 2019 Jun; 62():73-82. PubMed ID: 31153401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
    Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
    Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
    Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
    Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
    Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
    Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
    Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.
    Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.